BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lear W, Dahlke E, Murray CA. Basal Cell Carcinoma: Review of Epidemiology, Pathogenesis, and Associated Risk Factors. J Cutan Med Surg 2007;11:19-30. [DOI: 10.2310/7750.2007.00011] [Cited by in Crossref: 53] [Cited by in F6Publishing: 43] [Article Influence: 8.8] [Reference Citation Analysis]
Number Citing Articles
1 Scully C, Hegarty A. The Oral Cavity and Lips. In: Burns T, Breathnach S, Cox N, Griffiths C, editors. Rook's Textbook of Dermatology. Oxford: Wiley-Blackwell; 2010. pp. 1-129. [DOI: 10.1002/9781444317633.ch69] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
2 Chinem VP, Miot HA. Prevalence of actinic skin lesions in patients with basal cell carcinoma of the head: a case-control study. Revista da Associação Médica Brasileira 2012;58:188-96. [DOI: 10.1016/s0104-4230(12)70179-3] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
3 Kaeb S, Landthaler M, Hohenleutner U. Confocal laser scanning microscopy—evaluation of native tissue sections in micrographic surgery. Lasers Med Sci 2009;24:819-23. [DOI: 10.1007/s10103-009-0660-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
4 Harrison W, Cochrane B, Neill G, Philpott M. The oncogenic GLI transcription factors facilitate keratinocyte survival and transformation upon exposure to genotoxic agents. Oncogene 2014;33:2432-40. [PMID: 23792444 DOI: 10.1038/onc.2013.199] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
5 Tchernev G, Pidakev I, Lozev I, Lotti T, Wollina U. Multiple nonsyndromic acquired basal cell carcinomas : Uncommon clinical presentation in a Bulgarian patient. Wien Med Wochenschr 2017;167:134-8. [PMID: 28220371 DOI: 10.1007/s10354-017-0545-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
6 Corrêa Mde P, Ferreira AP, Gollner AM, Rodrigues MF, Guerra MC. [Markers expression of cell proliferation and apoptosis in basal cell carcinoma]. An Bras Dermatol 2009;84:606-14. [PMID: 20191172 DOI: 10.1590/s0365-05962009000600006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
7 Ziari K, Behdad B, Mohammadshahi A, Pirasteh HR, Sharifi MD, Dadpay M. Cellular and biological evaluation and diagnostic immunohistochemistry of cytokeratin 15/19 expression in distinguishing cutaneous basal cell carcinoma. Biologicals 2015;43:181-5. [PMID: 25748637 DOI: 10.1016/j.biologicals.2015.02.004] [Reference Citation Analysis]
8 Mokhtari M, Mesbah A, Rajabi P, Rajabi MA, Chehrei A, Mougouei K. Determination of the relationship between Basal cell carcinoma and human papilloma virus, based on immunohistochemistry staining method. Indian J Dermatol 2009;54:225-8. [PMID: 20161851 DOI: 10.4103/0019-5154.55629] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
9 Wrone DA, Sauder DN. Topical immunotherapy for skin disease. Expert Rev Clin Immunol 2007;3:451-4. [PMID: 20477149 DOI: 10.1586/1744666X.3.4.451] [Reference Citation Analysis]
10 Suchkov SV, Petrunin DD, Kostalevskaya AV, Kachkov IA, Elbeik T, Matsuura E, Paltsev MA. Cancer-associated immune-mediated syndromes: Pathogenic values and clinical implementation. Biomed Pharmacother 2007;61:323-37. [PMID: 17656060 DOI: 10.1016/j.biopha.2007.06.007] [Reference Citation Analysis]
11 Ballester-Sánchez R, Pons-Llanas O, Llavador-Ros M, Botella-Estrada R, Ballester-Cuñat A, Tormo-Micó A, Javier Celadá-Álvarez F, Rodríguez-Villalba S, Santos-Ortega M, Ballester-Pallarés F, Perez-Calatayud J. Depth determination of skin cancers treated with superficial brachytherapy: ultrasound vs. histopathology. J Contemp Brachytherapy 2015;6:356-61. [PMID: 25834579 DOI: 10.5114/jcb.2014.47860] [Cited by in Crossref: 3] [Cited by in F6Publishing: 15] [Article Influence: 0.4] [Reference Citation Analysis]
12 Pellegrini C, Orlandi A, Costanza G, Di Stefani A, Piccioni A, Di Cesare A, Chiricozzi A, Ferlosio A, Peris K, Fargnoli MC. Expression of IL-23/Th17-related cytokines in basal cell carcinoma and in the response to medical treatments. PLoS One 2017;12:e0183415. [PMID: 28829805 DOI: 10.1371/journal.pone.0183415] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
13 Montagna E, Lopes OS. Molecular basis of basal cell carcinoma. An Bras Dermatol 2017;92:517-20. [PMID: 28954101 DOI: 10.1590/abd1806-4841.20176544] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
14 Rivers JK, Mistry BD, Hung T, Vostretsova K, Mistry N. A 13-Year Retrospective Study of Basal Cell Carcinoma in a Canadian Dermatology Practice: A Comparison Between Anatomical Location and Histopathologic Subtypes. J Cutan Med Surg 2016;20:233-40. [PMID: 26631769 DOI: 10.1177/1203475415620396] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
15 Cojocaru A, Marinescu EA, Nica O, Ilinoiu E, Negrila A, Ciurea ME. Basal Cell Carcinoma and its Impact on Different Anatomical Regions. Curr Health Sci J 2021;47:75-83. [PMID: 34211751 DOI: 10.12865/CHSJ.47.01.12] [Reference Citation Analysis]
16 Armstrong LT, Magnusson MR, Guppy MP. Risk factors for recurrence of facial basal cell carcinoma after surgical excision: A follow-up analysis. Journal of Plastic, Reconstructive & Aesthetic Surgery 2017;70:1738-45. [DOI: 10.1016/j.bjps.2017.04.006] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
17 Beaulieu D, Nijhawan RI. Cells to Surgery Quiz: February 2018. J Invest Dermatol 2018;138:e21. [PMID: 29389332 DOI: 10.1016/j.jid.2017.12.012] [Reference Citation Analysis]
18 Eagan JT Jr, Jones CT. Cutaneous cancers in an interventional cardiologist: a cautionary tale. J Interv Cardiol 2011;24:49-55. [PMID: 21114530 DOI: 10.1111/j.1540-8183.2010.00610.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
19 Bánvölgyi A, Anker P, Lőrincz K, Kiss N, Márton D, Fésűs L, Gyöngyösi N, Wikonkál N. Smoothened receptor inhibitor vismodegib for the treatment of basal cell carcinoma: a retrospective analysis of efficacy and side effects. J Dermatolog Treat 2020;31:387-98. [PMID: 31039644 DOI: 10.1080/09546634.2019.1601155] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Craythorne E, Al-niami F. Skin cancer. Medicine 2017;45:431-4. [DOI: 10.1016/j.mpmed.2017.04.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 2.8] [Reference Citation Analysis]
21 Hallaji Z, Rahimi H, Mirshams-Shahshahani M. Comparison of risk factors of single Basal cell carcinoma with multiple Basal cell carcinomas. Indian J Dermatol 2011;56:398-402. [PMID: 21965847 DOI: 10.4103/0019-5154.84766] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
22 Wang J, Chen Y. Interleukin-6 -174 G/C polymorphism is associated with the risk of basal cell carcinoma in a Chinese Han population. Aging (Albany NY) 2020;12:15328-33. [PMID: 32859764 DOI: 10.18632/aging.103518] [Reference Citation Analysis]
23 Villalba SR, Perez-Calatayud MJ, Bautista JA, Carmona V, Celada F, Tormo A, García-Martinez T, Richart J, Ortega MS, Silla M, Ballester F, Perez-Calatayud J. Novel simple templates for reproducible positioning of skin applicators in brachytherapy. J Contemp Brachytherapy 2016;8:344-8. [PMID: 27648089 DOI: 10.5114/jcb.2016.61713] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
24 Kasumagic-Halilovic E, Hasic M, Ovcina-Kurtovic N. A Clinical Study of Basal Cell Carcinoma. Med Arch 2019;73:394-8. [PMID: 32082007 DOI: 10.5455/medarh.2019.73.394-398] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
25 Ferreira FR, Pevide Bda C, Rodrigues RF, Nascimento LF, Lira ML. Differences in age and topographic distribution of the different histological subtypes of basal cell carcinoma, Taubaté (SP), Brazil. An Bras Dermatol 2013;88:726-30. [PMID: 24173177 DOI: 10.1590/abd1806-4841.20132145] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
26 ShamsiMeymandi S, Dabiri S, ZeynadiniMeymand A, Iranpour M, Khalili M, Alijani S, Aflatoonian M. Evaluation of Immunohistochemical Findings and Clinical Features Associated with Local Aggressiveness in Basal Cell Carcinoma. Iran J Pathol 2019;14:193-6. [PMID: 31582995 DOI: 10.30699/ijp.2019.82907.1781] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
27 Ballester-Sánchez R, Pons-Llanas O, Candela-Juan C, Celada-Álvarez FJ, Barker CA, Tormo-Micó A, Pérez-Calatayud J, Botella-Estrada R. Electronic brachytherapy for superficial and nodular basal cell carcinoma: a report of two prospective pilot trials using different doses. J Contemp Brachytherapy 2016;8:48-55. [PMID: 26985197 DOI: 10.5114/jcb.2016.57531] [Cited by in Crossref: 16] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
28 Werner B, Mulinari-Brenner F. Saved by step sections: an unusual presentation of basal cell carcinoma. Dermatol Pract Concept 2011;1:49-52. [PMID: 24396719 DOI: 10.5826/dpc.0101a10] [Reference Citation Analysis]
29 Kocabaş E, Ermertcan AT, Bilaç C, Bilaç DB, Temiz P. Nonsyndromic multiple basal cell carcinomas successfully treated with imiquimod 5% cream. Cutaneous and Ocular Toxicology 2010;29:300-2. [DOI: 10.3109/15569527.2010.503177] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
30 Sidoroff A, Thaler P. Taking treatment decisions in non-melanoma skin cancer—The place for topical photodynamic therapy (PDT). Photodiagnosis and Photodynamic Therapy 2010;7:24-32. [DOI: 10.1016/j.pdpdt.2009.12.004] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 3.6] [Reference Citation Analysis]
31 Unal S, Cetin M, Gumruk F. Basal cell carcinoma after treatment of childhood acute lymphoblastic leukemia and concise review of the literature. Pediatr Dermatol 2015;32:e82-5. [PMID: 25781207 DOI: 10.1111/pde.12559] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
32 Zou Y, Zhao Y, Yu J, Luo X, Han J, Ye Z, Li J, Lin H. Photodynamic therapy versus surgical excision to basal cell carcinoma: meta-analysis. J Cosmet Dermatol 2016;15:374-82. [DOI: 10.1111/jocd.12236] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
33 Cardoso JC, Ribeiro IP, Caramelo F, Tellechea O, Barbosa de Melo J, Marques Carreira I. Basal cell carcinomas of the scalp after radiotherapy for tinea capitis in childhood: A genetic and epigenetic study with comparison with basal cell carcinomas evolving in chronically sun-exposed areas. Exp Dermatol 2021;30:1126-34. [PMID: 33205471 DOI: 10.1111/exd.14237] [Reference Citation Analysis]
34 Szeimies RM, Ibbotson S, Murrell DF, Rubel D, Frambach Y, de Berker D, Dummer R, Kerrouche N, Villemagne H; Excilight Study Group. A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8-20 mm), with a 12-month follow-up. J Eur Acad Dermatol Venereol 2008;22:1302-11. [PMID: 18624836 DOI: 10.1111/j.1468-3083.2008.02803.x] [Cited by in Crossref: 142] [Cited by in F6Publishing: 115] [Article Influence: 10.1] [Reference Citation Analysis]
35 Chinem VP, Miot HA. Epidemiology of basal cell carcinoma. An Bras Dermatol 2011;86:292-305. [PMID: 21603813 DOI: 10.1590/s0365-05962011000200013] [Cited by in Crossref: 66] [Cited by in F6Publishing: 35] [Article Influence: 6.6] [Reference Citation Analysis]
36 Worswick SD, Cockburn M, Peng D. Measurement of Ultraviolet Exposure in Epidemiological Studies of Skin and Skin Cancers. Photochemistry and Photobiology 2008;84:1462-72. [DOI: 10.1111/j.1751-1097.2008.00367.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
37 Goyal S, Shiver MB, Banda H, Brown HH, Pemberton JD. Nonhealing trauma masking periocular basal cell carcinoma in a young black male. Can J Ophthalmol 2014;49:e14-6. [PMID: 24513372 DOI: 10.1016/j.jcjo.2013.09.026] [Reference Citation Analysis]
38 Sabbatino F, Marra A, Liguori L, Scognamiglio G, Fusciello C, Botti G, Ferrone S, Pepe S. Resistance to anti-PD-1-based immunotherapy in basal cell carcinoma: a case report and review of the literature. J Immunother Cancer 2018;6:126. [PMID: 30458852 DOI: 10.1186/s40425-018-0439-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
39 Lien MH, Sondak VK. Nonsurgical treatment options for Basal cell carcinoma. J Skin Cancer 2011;2011:571734. [PMID: 21274437 DOI: 10.1155/2011/571734] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
40 Ahmed AH, Soyer HP, Saunders N, Boukamp P, Roberts MS. Non-melanoma skin cancers. Drug Discovery Today: Disease Mechanisms 2008;5:e55-62. [DOI: 10.1016/j.ddmec.2008.05.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
41 Pons-Llanas O, Ballester-Sánchez R, Celada-Álvarez FJ, Candela-Juan C, García-Martínez T, Llavador-Ros M, Botella-Estrada R, Barker CA, Ballesta A, Tormo-Micó A, Rodríguez S, Perez-Calatayud J. Clinical implementation of a new electronic brachytherapy system for skin brachytherapy. J Contemp Brachytherapy 2015;6:417-23. [PMID: 25834587 DOI: 10.5114/jcb.2014.47996] [Cited by in Crossref: 11] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
42 Mydlarz WK, Weber RS, Kupferman ME. Cutaneous malignancy of the head and neck. Surg Oncol Clin N Am 2015;24:593-613. [PMID: 25979402 DOI: 10.1016/j.soc.2015.03.010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
43 Uter W, Benz M, Mayr A, Gefeller O, Pfahlberg A. Assessing skin pigmentation in epidemiological studies: The reliability of measurements under different conditions. Skin Res Technol 2013;19:100-6. [DOI: 10.1111/srt.12013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
44 Cosgarea R, Susan M, Crisan M, Senila S. Photodynamic therapy using topical 5-aminolaevulinic acid vs. surgery for basal cell carcinoma. J Eur Acad Dermatol Venereol 2013;27:980-4. [PMID: 22738399 DOI: 10.1111/j.1468-3083.2012.04619.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 3.2] [Reference Citation Analysis]
45 Chen N, Scarpa R, Zhang L, Seiberg M, Lin CB. Nondenatured soy extracts reduce UVB-induced skin damage via multiple mechanisms. Photochem Photobiol 2008;84:1551-9. [PMID: 18627522 DOI: 10.1111/j.1751-1097.2008.00383.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
46 Donovan J. Review of the hair follicle origin hypothesis for basal cell carcinoma. Dermatol Surg 2009;35:1311-23. [PMID: 19496793 DOI: 10.1111/j.1524-4725.2009.01236.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]